All In Biotech

Drug Trial Radar · NCT02322866

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 1.5 mg/kg Per Day of Sarecycline Compared to Placebo in the Treatment of Acne Vulgaris

Last checked: Nov 20, 2026Latest source record: Feb 1, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,034 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,034

Actual

Start

Dec 3, 2014

Primary completion

Jan 12, 2017

Study completion Jan 12, 2017

Sponsor

Lead sponsor
Almirall, S.A.Industry
Sponsor type
Industry
Collaborators
Allergan
First posted
Dec 23, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 9 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of an approximate 1.5 mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris

Conditions

  • Acne Vulgaris

Interventions

  • SarecyclineDrug

    1.5 mg/kg/day taken orally at the same time each day.

  • PlaceboDrug

    Placebo-matching sarecycline tablets, taken orally at the same time each day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute Change From Baseline in Facial Inflammatory Lesion Counts at Week 12Time frame: Baseline (Day 1) to Week 12
  2. Percentage of Participants With Investigator's Global Assessment (IGA) Scale Success at Week 12Time frame: Week 12

Locations

57 sites in 1 country. Site status is shown where the registry gives one.

  • Warner Chilcott Research Site (Site #206)

    Mobile, Alabama

  • Warner Chilcott Research Site (Site #236)

    Hot Springs, Arkansas

  • Warner Chilcott Research Site (Site #245)

    Carlsbad, California

  • Warner Chilcott Research Site (Site #234)

    Encinitas, California

  • Warner Chilcott Research Site (Site #209)

    Fremont, California

  • Warner Chilcott Research Site (Site #215)

    Oceanside, California

  • Warner Chilcott Research Site (Site #204)

    San Diego, California

  • Warner Chilcott Research Site (Site #254)

    San Diego, California

  • Warner Chilcott Research Site (Site #257)

    Santa Ana, California

  • Warner Chilcott Research Site (Site #243)

    Santa Monica, California

  • Warner Chilcott Research Site (Site #222)

    Denver, Colorado

  • Warner Chilcott Research Site (Site #237)

    Aventura, Florida

  • Warner Chilcott Research Site (Site #226)

    Clearwater, Florida

  • Warner Chilcott Research Site (Site #238)

    Jupiter, Florida

  • Warner Chilcott Research Site (Site #255)

    Lauderdale Lakes, Florida

  • Warner Chilcott Research Site (Site #249)

    Miami, Florida

  • Warner Chilcott Research Site (Site #202)

    Miami, Florida

  • Warner Chilcott Research Site (Site #211)

    Miramar, Florida

  • Warner Chilcott Research Site (Site #247)

    Ocala, Florida

  • Warner Chilcott Research Site (Site #241)

    Orlando, Florida

  • Warner Chilcott Research Site (Site #228)

    Pinellas Park, Florida

  • Warner Chilcott Research Site (Site #203)

    Tampa, Florida

  • Warner Chilcott Research Site (Site #242)

    Snellville, Georgia

  • Warner Chilcott Research Site (Site #210)

    Champaign, Illinois

  • Warner Chilcott Research Site (Site #213)

    Louisville, Kentucky

  • Warner Chilcott Research Site (Site #217)

    Rockville, Maryland

  • Warner Chilcott Research Site (Site #248)

    Watertown, Massachusetts

  • Warner Chilcott Research Site (Site #205)

    Bay City, Michigan

  • Warner Chilcott Research Site (Site #251)

    Clarkston, Michigan

  • Warner Chilcott Research Site (Site #235)

    Clinton Township, Michigan

  • Warner Chilcott Research Site (Site #227)

    Fort Gratiot, Michigan

  • Warner Chilcott Research Site (Site #221)

    Fridley, Minnesota

  • Warner Chilcott Research Site (Site #231)

    Omaha, Nebraska

  • Warner Chilcott Research Site (Site #253)

    Newington, New Hampshire

  • Warner Chilcott Research Site (Site #239)

    Albuquerque, New Mexico

  • Warner Chilcott Research Site (Site #208)

    New York, New York

  • Warner Chilcott Research Site (Site #240)

    Rochester, New York

  • Warner Chilcott Research Site (Site #230)

    Stony Brook, New York

  • Warner Chilcott Research Site (Site #229)

    Raleigh, North Carolina

  • Warner Chilcott Research Site (Site #250)

    Wilmington, North Carolina

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.